WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
CLSI has a longstanding globally trusted reputation for its diligent development of Microbiology and Antimicrobial Susceptibility Testing (AST) standards and guidelines on test methods and QC procedures. Additionally, CLSI annually creates and revises AST breakpoints to meet global public health challenges related to antimicrobial resistance. CLSI’s library of Microbiology standards and AST guidelines establish vital performance criteria and best practice guidelines for use in the clinical microbiology laboratory field.
This document includes minimal inhibitory concentration breakpoints and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents M38 and M51.
This document includes updated minimal inhibitory concentration, zone diameter, and quality control tables for the Clinical and Laboratory Standards Institute antifungal susceptibility testing documents M27 and M44.
This document includes epidemiological cutoff values developed according to the criteria in the Clinical and Laboratory Standards Institute (CLSI) guideline M57 and generated according to the reference broth dilution methods described in the CLSI standards M27 and M38.
Susceptibility testing of mycobacteria will be discussed in this upcoming webinar. Speakers will: -Discuss current methods for phenotypic and genotypic antimicrobial susceptibility testing (AST) of Mycobacterium tuberculosis complex (MTBC). -Review new and evolving standards for non-tuberculous Mycobacterium spp. -Evaluate updated guidance from the forthcoming CLSI Standard M24. -Review recent changes that impact AST for MTBC.
